FDA Enables Generic Insulins with Lower Prices
Insulin Nation
MARCH 26, 2020
Sanofi, NovoNordisk, and Lilly have created huge and profitable businesses by filing hundreds of patents for every type of insulin in order to prevent generics from being legally possible. These critical therapies often carry a heavy price tag; the cost of insulin has risen over the past decade.
Let's personalize your content